GUIDELINES FOR DIAGNOSTICS AND TREATMENT OF SARCOIDOSIS
Abstract
.Downloads
References
Costabel U. Sensitivity and specificity of BAL findings in sarcoidosis. Sarcoidosis 1992; 9: Suppl 1: 211–4.
Fortič B, Skralovnik-Štern A. Sarkoidoza v svetu in v Sloveniji. In: Dolenc A, Fortič B, Rott T, Štangl B. Pljučne granulomatoze. XVI. memorialni sestanek Janeza Plečnika. Ljubljana: Medicinski razgledi, 1985: 279–314.
Šorli J, Debeljak A, Rott T, Ferluga D. Diagnostika sarkoidoze. Zdrav Vestn 1987; 56: 419–22.
Roethe RA, Fuller PB, Byrd RB et al. Transbronchial lung biopsy in sarcoidosis. Chest 1980; 77: 400–2
Debeljak A, Zupančič M, Remškar J et al. Transbronchial lung biopsy for diffuse pulmonary diseases. Atemweg Lungenkrkh 1990; 16: 91–2.
Debeljak A. Bronhoalveolarno izpiranje pri sarkoidozi. Med Razgl 1985; Suppl 4: 375–82.
Gossot D, Toledo L, Fritsch S, Celerier M. Mediastinoscopy vs. thoracoscopy for mediastinal biopsy. Results of a prospective nonrandomised study. Chest 1996; 110: 1328–31.
Eržen D, Šorli J, Žolnir-Dovč M. Poročilo o tuberkulozi v Sloveniji v letih 1998 in 1999. Golnik: Publikacija Centralnega registra za tuberkulozo, Golnik, 2001: 9–61.
Wilsher ML, Menzies RE, Croxson MC. Mycobacterium tuberculosis DNA in tissues affected by sarcoidosis. Thorax 1998; 53: 871–4.
Žolnir-Dovč M. Posebnosti pri odvzemu in prenosu kužnin v primeru suma na tuberkulozo. In: Mikrobiološka analiza kužnin. Zbornik strokovnega srečanja Sekcije za klinično mikrobiologijo in hospitalne infekcije SZD ter Združenja za infektologijo pri SZD, Nova Gorica,1999: 83–9.
Žolnir-Dovč M, Poljak M, Seme K. Molekularna diagnostika tuberkuloze – upanje ali iluzija? Med Razgl 1996; 35: 501–12.
Žolnir-Dovč M, Poljak M, Seme K, Rus A, Avšič-Županc T. Evaluation of two commercial amplification assays for detection of M. tuberculosis complex in respiratory specimens. Infection 1995; 23: 216–21.
Skralovnik-Štern A, Štern A. Potek in prognoza sarkoidoze. In: Dolenc A, Fortič B, Rott T, Štangl B. Pljučne granulomatoze. XVI. memorialni sestanek Janeza Plečnika. Ljubljana: Medicinski razgledi, 1985: 315–39.
Rizzato G, Montemurro M, Colombo P. The late follow up of chronic sarcoid patients previously treated with corticosteroids. Sarc Vasc Diffuse Lung Dis 1998; 15: 52–8.
Newman LS, Rose CS, Maier LA. Sarcoidosis. N Engl J Med 1997; 336: 1224–4.
Fireman E et al. Induced sputum compared to bronchoalveolar lavage for evaluating patients with sarcoidosis and non-granulomatous interstitial lung disease. Respir Med 1999; 93: 827–34.
Yuben PM et al. Correlation of CD4:CD8 ratio and TNF-levels in induced sputum with bronchoalveolar lavage fluid in pulmonary sarcoidosis. Thorax 2000; 55: 696–9.
Kim DS, Jeon YG, Shim TS et al. The value of IL-12 as an activity marker of pulmonary sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 2000; 17: 271–6.
Downloads
Published
Issue
Section
License
The Author transfers to the Publisher (Slovenian Medical Association) all economic copyrights following form Article 22 of the Slovene Copyright and Related Rights Act (ZASP), including the right of reproduction, the right of distribution, the rental right, the right of public performance, the right of public transmission, the right of public communication by means of phonograms and videograms, the right of public presentation, the right of broadcasting, the right of rebroadcasting, the right of secondary broadcasting, the right of communication to the public, the right of transformation, the right of audiovisual adaptation and all other rights of the author according to ZASP.
The aforementioned rights are transferred non-exclusively, for an unlimited number of editions, for the term of the statutory
The Author can make use of his work himself or transfer subjective rights to others only after 3 months from date of first publishing in the journal Zdravniški vestnik/Slovenian Medical Journal.
The Publisher (Slovenian Medical Association) has the right to transfer the rights of acquired parties without explicit consent of the Author.
The Author consents that the Article be published under the Creative Commons BY-NC 4.0 (attribution-non-commercial) or comparable licence.